Friedman, Debra L.

Assessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model

Johnson, D., Goodman, R., Patrinely, J., Stone, C., Zimmerman, E., Donald, R., Chang, S., Berkowitz, S., Finn, A., Jahangir, E., et al. (2023) · Research Square

Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare

Cited by 598

Accuracy and Reliability of Chatbot Responses to Physician Questions

Goodman, R. S., Patrinely, J. R., Stone, C. A., Zimmerman, E., Donald, R. R., Chang, S. S., Berkowitz, S. T., Finn, A. P., Jahangir, E., Scoville, E. A., et al. (2023) · JAMA Network Open

Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare

Cited by 484

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Denlinger, C. S., Sanft, T., Baker, K. S., Broderick, G., Demark-Wahnefried, W., Friedman, D. L., Goldman, M., Hudson, M., Khakpour, N., King, A., et al. (2018) · Journal of the National Comprehensive Cancer Network

Cancer survivorship and careChemotherapy-induced cardiotoxicity and mitigation

Cited by 199

Availability and Use of Palliative Care and End-of-Life Services for Pediatric Oncology Patients

Johnston, D. L., Nagel, K., Friedman, D. L., Meza, J. L., Hurwitz, C. A., & Friebert, S. (2008) · Journal of Clinical Oncology

Palliative and Oncologic CarePalliative Care and End-of-Life Issues

Cited by 150

Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center

Johnson, D. B., Friedman, D. L., Berry, E., Decker, I., Ye, F., Zhao, S., Morgans, A. K., Puzanov, I., Sosman, J. A., & Lovly, C. M. (2015) · Cancer Immunology Research

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 101

Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand

Patrinely, J. R., Young, A. C., Quach, H., Williams, G. R., Ye, F., Fan, R., Horn, L., Beckermann, K. E., Gillaspie, E. A., Sosman, J. A., et al. (2020) · European Journal of Cancer

Cancer Immunotherapy and BiomarkersCancer survivorship and care

Cited by 61

Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort

Castel, L. D., Hartmann, K. E., Mayer, I. A., Saville, B. R., Alvarez, J., Boomershine, C. S., Abramson, V. G., Chakravarthy, A. B., Friedman, D. L., & Cella, D. F. (2013) · Cancer

Breast Cancer Treatment StudiesMenopause: Health Impacts and Treatments

Cited by 43